// App-Quantinova.ai

1444 : Interm Report of the Highlow Study: A Randomized Controlled Trial Comparing Two Doses of Low Molecular Weight Heparin for the Prevention of Pregnancy-Associated Recurrent Venous Thromboembolism

Researchers

Presenter

  • Suzanne M Bleker

Principal Investigators

  • Bistervels M Ingrid

  • Andrea Buchmuller

  • Celine Chauleur

  • Fionnuala Ni Ainle

  • Jennifer Donnelly

  • Peter Verhamme

  • Anne Flem Jacobsen

  • Herve Decousus

  • Saskia Middeldorp

Medical Centers

  • Dept of Neonatology, Rotunda Hospital, Dublin, Ireland

  • Pulmonary Medicine, Academic Medical Centre, Amsterdam, Netherlands

  • - F Crin, INNOVTE, CHU Saint-Etienne, Hopital Nord, Service Medecine Vasculaire et Therapeutique, Saint-Etienne, Saint Etienne, France

  • KU Leuven, Leuven, Belgium

  • Department Medical Oncology Mater Misericordiae University Hospital, Dublin, Ireland

  • Department of Gynaecology and Obstetrics, Oslo University Hospital, Oslo, Norway

  • Pulmonary Medicine, Academic Medical Centre, Amsterdam, Netherlands

  • CHU Saint-Etienne, Hopital Nord, Service de Gyneco-Obstetrique, Saint Etienne, France

  • - F Crin, INNOVTE, CHU Saint-Etienne, Hopital Nord, Service Medecine Vasculaire et Therapeutique, Saint-Etienne, Saint Etienne, France

  • Mater Misericordiae University Hospital and Rotunda Hospital, SPHERE Research Group, University College Dublin School of Medicine, Dublin, Ireland

  • Inserm, U

Locations

  • Ireland

  • Norway

  • Netherlands

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved